Microbes and Cancer: Friends or Faux?

被引:66
作者
Azevedo, Maria Manuel [1 ,2 ,3 ]
Pina-Vaz, Cidalia [1 ,2 ]
Baltazar, Fatima [4 ,5 ,6 ]
机构
[1] Univ Porto, Fac Med, Dept Microbiol, P-4200319 Porto, Portugal
[2] Univ Porto, Fac Med, CINTESIS, P-4200319 Porto, Portugal
[3] Agrp Escolas D Maria II, P-4760067 V N Famalicao, Portugal
[4] Univ Minho, Sch Med, Life & Hlth Sci Res Inst ICVS, Campus Gualtar, P-4710057 Braga, Portugal
[5] ICVS 3Bs PT Govt Associate Lab, P-4710057 Braga, Portugal
[6] ICVS 3Bs PT Govt Associate Lab, P-4835258 Guimaraes, Portugal
关键词
cancer; infection; microbiome; cancer dysbiosis; tumor microbiome; cancer therapy response; EPSTEIN-BARR-VIRUS; INVASIVE FUNGAL-INFECTIONS; NON-HODGKINS-LYMPHOMA; PANCREATIC-CANCER; HELICOBACTER-PYLORI; GUT MICROBIOTA; GASTRIC-CANCER; TRANSPLANT RECIPIENTS; COLORECTAL-CANCER; CURRENT KNOWLEDGE;
D O I
10.3390/ijms21093115
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Cancer is one of the most aggressive and deadly diseases in the world, representing the second leading cause of death. It is a multifactorial disease, in which genetic alterations play a key role, but several environmental factors also contribute to its development and progression. Infections induced by certain viruses, bacteria, fungi and parasites constitute risk factors for cancer, being chronic infection associated to the development of certain types of cancer. On the other hand, susceptibility to infectious diseases is higher in cancer patients. The state of the host immune system plays a crucial role in the susceptibility to both infection and cancer. Importantly, immunosuppressive cancer treatments increase the risk of infection, by decreasing the host defenses. Furthermore, alterations in the host microbiota is also a key factor in the susceptibility to develop cancer. More recently, the identification of a tumor microbiota, in which bacteria establish a symbiotic relationship with cancer cells, opened a new area of research. There is evidence demonstrating that the interaction between bacteria and cancer cells can modulate the anticancer drug response and toxicity. The present review focuses on the interaction between microbes and cancer, specifically aiming to: (1) review the main infectious agents associated with development of cancer and the role of microbiota in cancer susceptibility; (2) highlight the higher vulnerability of cancer patients to acquire infectious diseases; (3) document the relationship between cancer cells and tissue microbiota; (4) describe the role of intratumoral bacteria in the response and toxicity to cancer therapy.
引用
收藏
页数:23
相关论文
共 189 条
  • [21] Birrie H, 1998, E AFR MED J, V75, P311
  • [22] The influence of oral hygiene on salivary quality in the ames test, as a marker for genotoxic effects
    Bloching, Marc
    Reich, Waldemar
    Schubert, Johannes
    Grummt, Tamara
    Sandner, Annett
    [J]. ORAL ONCOLOGY, 2007, 43 (09) : 933 - 939
  • [23] Bosch FX, 2013, VACCINE, V31, pF1, DOI [10.1016/j.vaccine.2013.07.026, 10.1016/j.vaccine.2013.10.003, 10.1016/j.vaccine.2013.10.001]
  • [24] Primary liver cancer:: Worldwide incidence and trends
    Bosch, FX
    Ribes, J
    Díaz, M
    Cléries, R
    [J]. GASTROENTEROLOGY, 2004, 127 (05) : S5 - S16
  • [25] Botelho MC, 2017, INT J CANCER MANAG, V10, DOI 10.5812/ijcm.9430
  • [26] Schistosoma haematobium total antigen induces increased proliferation, migration and invasion, and decreases apoptosis of normal epithelial cells
    Botelho, Monica Catarina
    Machado, Jose Carlos
    Correia da Costa, Jose Manuel
    [J]. VIRULENCE, 2010, 1 (02) : 84 - 87
  • [27] Schistosoma haematobium: Identification of new estrogenic molecules with estradiol antagonistic activity and ability to inactivate estrogen receptor in mammalian cells
    Botelho, Monica Catarina
    Soares, Raquel
    Vale, Nuno
    Ribeiro, Ricardo
    Camilo, Vania
    Almeida, Raquel
    Medeiros, Rui
    Gomes, Paula
    Machado, Jose Carlos
    Correia da Costa, Jose Manuel
    [J]. EXPERIMENTAL PARASITOLOGY, 2010, 126 (04) : 526 - 535
  • [28] Brady G, 2007, J CLIN PATHOL, V60, P1397, DOI 10.1136/jcp.2007.047977
  • [29] The cytostatic activity of pyrimidine nucleosides is strongly modulated by Mycoplasma hyorhinis infection:: Implications for cancer therapy
    Bronckaers, Annelies
    Balzarini, Jan
    Liekens, Sandra
    [J]. BIOCHEMICAL PHARMACOLOGY, 2008, 76 (02) : 188 - 197
  • [30] Emerging roles of the microbiome in cancer
    Bultman, Scott J.
    [J]. CARCINOGENESIS, 2014, 35 (02) : 249 - 255